PRF Technologies (PRFX) Total Liabilities (2019 - 2025)
PRF Technologies (PRFX) posted quarterly Total Liabilities of $2.7 million for Q4 2025, little changed year-on-year from $2.7 million in Q4 2024, and little changed on a QoQ basis from $2.7 million in Q2 2025.
PRF Technologies (PRFX) Total Liabilities (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has reported Total Liabilities for 7 consecutive years, with $2.7 million the latest figure, recorded in Q4 2025.
- Quarterly Total Liabilities changed 0.26% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (changed 0.26% YoY) and the FY2025 annual result came in at $2.7 million, changed 0.26% from the prior year.
- Total Liabilities was little changed at $2.7 million in Q4 2025 per PRFX's latest filing, from $2.7 million in the prior quarter.
- Over the last five years, Total Liabilities for PRFX reached as high as $21.4 million in Q1 2021 and fell as low as $787000.0 in Q2 2022.
- A 5-year average of $3.1 million and a median of $1.5 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities slumped 95.3% — and 2024, when it jumped 283.32%.
- Year by year, Total Liabilities stood at $991000.0 in 2021, then surged by 31.89% to $1.3 million in 2022, then soared by 37.72% to $1.8 million in 2023, then jumped by 50.06% to $2.7 million in 2024, then rose by 0.26% to $2.7 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $2.7 million, $2.7 million, and $2.7 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.71 Mn |
| Jun 30, 2025 | 2.72 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Mar 31, 2024 | 3.52 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.43 Mn |
| Jun 30, 2022 | 787,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 991,000.00 |
| Sep 30, 2021 | 856,000.00 |
| Jun 30, 2021 | 833,000.00 |
| Mar 31, 2021 | 21.35 Mn |
| Dec 31, 2020 | 1.18 Mn |
| Jun 30, 2020 | 838,000.00 |
| Dec 31, 2019 | 1.16 Mn |